Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2023-02-02 00:00:00 ET · period of report 2023-01-31 · accession 0001209191-23-006417 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-02 | 2023-01-31 | TVTX | Dube Eric M | CEO, Dir | A - Grant | $0.00 | +97.5K | 245.3K | +66% | $0 |
| D | 2023-02-02 | 2023-02-01 | TVTX | Dube Eric M | CEO, Dir | S - Sale | $22.25 | -8,196 | 237.2K | -3% | -$182.4K |
| DM | 2023-02-02 | 2023-01-31 | TVTX | Dube Eric M | CEO, Dir | A - Grant | $0.00 | +292.5K | 32.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-31 | A | A | 97,500 | $0.00 | 245,346 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-01 | S | D | 8,196 | $22.25 | 237,150 | D | — | — | |
| 3 | Derivative | Employee stock option (right to buy) | 2023-01-31 | A | A | 260,000 | $0.00 | 260,000 | D | $22.40 · — to 2033-01-30 | 260,000 Common Stock | (F3) One-fourth of the shares subject to the stock option vest and become exercisable on the first anniversary of the date of grant, and the remaining shares vest in 36 equal monthly installments thereafter. |
| 4 | Derivative | Performance-based restricted stock units | 2023-01-31 | A | A | 32,500 | $0.00 | 32,500 | D | — · — to — | 32,500 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of the Common Stock of the Issuer. (F4) This grant will vest upon the achievement of a specified clinical/regulatory milestone, provided, however, if the vesting event occurs before the date that is 12 months after the date of grant, then the award will instead vest on the date that is 12 months after the date of grant, and provided further that the Performance RSU will expire on January 31, 2027 if the specified performance based milestone is not achieved by such date. |